MAKSIM MERENKOV: Open Payments
NPI 1407408032 · WESTFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 32 payments from 12 companies in 2025. Trend: 2023 $1,985 · 2024 $1,451 · 2025 $918
Food & beverage: $856Education: $63
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 11 | $374 |
| E.R. Squibb & Sons, L.L.C. | 4 | $112 |
| Alnylam Pharmaceuticals Inc. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Esperion Therapeutics, Inc. | 1 | $63 |
| SCPHARMACEUTICALS INC. | 2 | $51 |
| Actelion Pharmaceuticals US, Inc. | 1 | $42 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: LUX-Dx Insertable Cardiac Monitor, ONPATTRO, ELIQUIS, NEXLETOL, LEQVIO, FUROSCIX, CAMZYOS, OPSUMIT.
Industry payments across MA — which companies pay providers there.
